Equillium, Inc. logo

Equillium, Inc.


Overview | Financials
Company Name Equillium, Inc.
Symbol EQ
Currency USD
Price 0.842
Market Cap 29,695,118
Dividend Yield 0%
52-week-range 0.45 - 3.25
Industry Biotechnology
Sector Healthcare
CEO Mr. Bruce D. Steel C.F.A.
Website https://equilliumbio.com

An error occurred while fetching data.

About Equillium, Inc.

Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. The company's lead product candidate is itolizumab (EQ001), a clinical-stage monoclonal antibody that targets the novel immune checkpoint receptor CD6, which is in Phase III clinical trials

Related Stocks

Fortress Biotech, Inc. logo

Fortress Biotech, Inc.


1.93 USD

Celcuity Inc. logo

Celcuity Inc.


17.77 USD

Surrozen, Inc. logo

Surrozen, Inc.


9.23 USD

Trevi Therapeutics, Inc. logo

Trevi Therapeutics, Inc.


2.8 USD

Aptose Biosciences Inc. logo

Aptose Biosciences Inc.


0.71 USD

iCAD, Inc. logo

iCAD, Inc.


1.3 USD


Numbers are in millions USD

Numbers are in millions USD